Global Peripheral Stent Implants Market Forecast
• Global peripheral stent implants market size to reach US$7.1 Bn in 2031, up from US$3.9 Bn estimated in 2024
• Market revenue projected to exhibit a remarkable rate of expansion, at an estimated CAGR of 8.9 % during 2024 - 2031
Quick Report Digest
- The global peripheral stent implants market size will nearly double between the years of forecast, 2024 and 2031.
- Market growth between 2019 and 2023 was consistent, likely driven by an increase in peripheral artery disease (PAD) cases, and a preference for minimally invasive procedures.
- Technological advancements, an ageing population, and a rise in lifestyle diseases contribute to market expansion.
- Key growth determinants include continuous innovation in stent design, increasing prevalence of chronic diseases, and the shift towards minimally invasive procedures.
- Regulatory challenges, high costs, and competition from alternative treatments are major growth barriers for the market.
- Personalised medicine, bioresorbable stents, and emerging markets present significant trends and opportunities.
- The regulatory environment significantly shapes the industry by impacting product approvals, reimbursements, and innovation.
- Top segments include drug-eluting stents (DES), bare metal stents (BMS), and covered stents, with each offering distinct advantages.
- North America leads the market due to high PAD prevalence, advanced healthcare systems, and strong adoption of minimally invasive procedures.
- Key players in the global peripheral stent implants space include Abbott Laboratories, Boston Scientific Corporation, and Medtronic plc.
A Look Back and a Look Forward - Comparative Analysis
The peripheral stent implant market saw consistent growth between 2019 and 2023. This surge likely stemmed from a rise in peripheral artery disease (PAD), where arteries clog and limit blood flow to the legs. An ageing population more prone to PAD, coupled with a growing preference for minimally invasive stent procedures over open surgeries, likely fuelled market expansion during this period. Bare metal stents reigned supreme in terms of market share. The US held a dominant regional position.
Looking forward (2024-2031), the market is poised for continued growth at a healthy rate of growth. Several factors are expected to propel this growth, including the globally expanding elderly population susceptible to PAD, rise in lifestyle diseases like diabetes and obesity that increase PAD risk, and continuous advancements in minimally invasive techniques and peripheral stent technology. However, high procedure costs might pose a slight hurdle.
Key Growth Determinants
Technological Advancements
Continuous innovation in stent design, materials, and coatings has significantly enhanced the efficacy and safety of peripheral stent implants. Advancements such as drug-eluting stents, bioresorbable stents, and improved delivery systems have widened the application spectrum and improved patient outcomes, driving market growth.
Ageing Population, and Prevalence of Chronic Diseases
The increasing prevalence of peripheral artery disease (PAD), and other vascular conditions, coupled with a growing ageing population globally, fuels demand for peripheral stent implants. As the elderly population grows, so does the incidence of conditions requiring vascular interventions, thereby boosting the adoption of stent implants for peripheral artery revascularisation.
Minimally Invasive Procedures
The shift towards minimally invasive procedures has led to a surge in demand for peripheral stent implants. Patients and clinicians alike prefer these procedures due to reduced trauma, shorter recovery times, and lower healthcare costs compared to traditional open surgeries. As technological advancements continue to enable safer and more effective minimally invasive interventions, the peripheral stent implants market is expected to experience sustained growth.
Major Growth Barriers
Regulatory Challenges
Stringent regulatory approval processes, particularly in regions like the US, and Europe, pose a significant barrier to market growth. Complex regulatory requirements increase the time and cost associated with bringing new peripheral stent products to market, thereby limiting innovation and expansion opportunities for manufacturers.
High Costs, and Reimbursement Issues
The high initial costs associated with peripheral stent implants, including device procurement and procedural expenses, can deter healthcare facilities from adopting these technologies.
Additionally, reimbursement issues and inadequate coverage by insurance providers in certain markets create financial barriers for patients seeking peripheral artery revascularisation, thereby constraining market growth.
Competition from Alternative Treatments
The peripheral stent implants market faces competition from alternative treatment modalities such as balloon angioplasty, atherectomy, and bypass surgery. These alternatives may be preferred in certain clinical scenarios or by clinicians with specific expertise, leading to market fragmentation and limiting the growth potential of peripheral stent implants.
Key Trends and Opportunities to Look at
- Personalised Medicine, and Precision Healthcare
Recent advancements in medical imaging technologies and computational modelling have enabled the customisation of peripheral stent implants to individual patient anatomies and pathologies. This trend towards personalised medicine allows for the development of patient-specific treatment plans, optimising stent selection, sizing, and placement for improved outcomes. By tailoring interventions to each patient's unique characteristics, clinicians can enhance the efficacy of peripheral stent implants while minimising procedural risks and complications.
- Shift Towards Bioresorbable Stents
There is a growing interest in bioresorbable stents as an alternative to traditional metallic stents in peripheral artery revascularisation procedures. Bioresorbable stents gradually degrade and are absorbed by the body over time, potentially reducing the long-term risk of complications such as restenosis and thrombosis.
This trend aligns with the broader movement towards biodegradable medical devices and implants, driven by the desire to improve long-term patient outcomes and reduce the need for secondary interventions.
- Emerging Markets Expansion
There is significant untapped potential for peripheral stent implants in emerging markets, particularly in regions with rapidly growing healthcare infrastructure and increasing prevalence of cardiovascular diseases.
Market players can capitalise on these opportunities by expanding their presence in emerging economies, forging strategic partnerships with local healthcare providers, and tailoring their product offerings to meet the unique needs and preferences of these markets.
Moreover, investments in healthcare infrastructure development and initiatives to improve access to affordable healthcare services in emerging markets can further stimulate demand for peripheral stent implants.
How Does the Regulatory Scenario Shape this Industry?
The regulatory environment plays a vital role in the Peripheral Stent Implant market. Stringent regulations by bodies like the FDA ensure patient safety through demanding stent design, manufacturing, and clinical trial protocols. This, however, can extend the time and resources needed to introduce new stents, potentially hindering innovation.
Reimbursement policies set by governments and insurance agencies dictate the rates hospitals receive for stent procedures. Strict regulations or low reimbursements can disincentivise hospitals from adopting new stents, impacting the market growth of novel technologies. Product recalls mandated by regulators in case of safety concerns can severely damage a manufacturer's reputation and disrupt market stability.
Regulatory bodies might also favour drug-eluting stents over bare metal stents due to potential long-term benefits for patients, influencing market share dynamics. The regulatory landscape significantly shapes the peripheral stent implant market by impacting product approvals, reimbursements, and technological advancements. While regulations ensure patient safety, they can also pose challenges for innovation and market expansion.
Fairfield’s Ranking Board
Top Segments
- Excellent Safety and Performance Profile Account for Drug Eluting Stents (DES)
Drug eluting stents (DES) are currently one of the top-performing segments in the market due to their ability to release medication to prevent restenosis. Their popularity stems from their efficacy in reducing the need for repeat procedures and improving patient outcomes. DES offer advantages over bare metal stents (BMS) by minimising the risk of tissue regrowth within the stent, thereby reducing the occurrence of blockages.
Additionally, advancements in DES technology such as biodegradable polymers, and novel drug coatings have further enhanced their performance and safety profile. The increasing prevalence of peripheral artery disease (PAD), and the growing adoption of minimally invasive procedures are driving the demand for DES, making it a lucrative segment in the market.
- Cost Efficiency Drives Demand in Bare Metal Stents (BMS)
Despite facing competition from drug eluting stents (DES), bare metal stents (BMS) remain a significant segment in the peripheral stent implants market. BMS are preferred in certain clinical scenarios where the risk of long-term antiplatelet therapy is a concern, such as in patients with high bleeding risk or those needing urgent interventions.
Furthermore, BMS are cost-effective compared to DES, making them a preferred choice in resource-limited settings or for patients with financial constraints. The simplicity of BMS, coupled with their durability and ease of deployment, continues to maintain their relevance in peripheral artery interventions. However, advancements in DES technology have somewhat overshadowed BMS in recent years, leading to a gradual decline in market share for this segment.
- Covered Stents Gain Traction in the Wake of Growing Vascular Disease Prevalence
Covered stents have emerged as a promising segment in the peripheral stent implants market, particularly in the treatment of complex peripheral artery lesions such as aneurysms, dissections, and pseudoaneurysms. Unlike traditional stents, covered stents feature a membrane or fabric covering that provides a scaffold for vessel repair and prevents embolisation or leakage.
The unique design allows covered stents to effectively seal off defects in diseased vessels, reducing the risk of complications and improving patient outcomes. Covered stents offer a minimally invasive alternative to open surgical procedures, leading to shorter hospital stays and faster recovery times.
The growing incidence of vascular diseases, coupled with advancements in stent technology and increased physician expertise in endovascular interventions, is driving the demand for covered stents. As a result, this segment is experiencing significant growth and is expected to continue expanding in the foreseeable future.
Regional Frontrunners
- North America’s Dominance to Continue Through 2031
This region dominates due to several factors. The US has a high prevalence of PAD due to an ageing population and a high rate of lifestyle diseases like diabetes and obesity. The US healthcare system facilitates access to advanced medical technologies like stents. There is strong adoption of minimally invasive procedures and a presence of major market players in the region.
- Asia Pacific, and Europe Grow Significant
This region is witnessing a rapid rise in PAD cases on the back of growing economies leading to increased healthcare spending, and improving medical infrastructure, making peripheral stent implants more accessible.
Europe also has a well-established healthcare system with a high adoption rate of advanced medical technologies. An ageing population further fuels market growth. However, stringent regulations might slightly impede market expansion compared to other regions.
Fairfield’s Competitive Landscape Analysis
The competition landscape of the peripheral stent implants market is characterised by intense rivalry among key players striving to maintain or enhance their market positions. Leading companies in this sector include Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Terumo Corporation, and Cook Medical.
These companies employ various growth strategies to gain a competitive edge, including product innovation through continuous research and development efforts aimed at introducing advanced stent designs, materials, and coatings to improve efficacy and safety. Additionally, strategic collaborations, partnerships, and acquisitions play a vital role in expanding market presence, accessing new technologies, and strengthening distribution networks.
Furthermore, market players focus on geographic expansion by targeting emerging markets with growing healthcare infrastructure and increasing prevalence of peripheral artery diseases, thereby tapping into new growth opportunities, and diversifying their revenue streams. The competition landscape remains dynamic, with companies adopting multifaceted approaches to drive innovation and sustain growth in the Peripheral Stent Implants Market.
Who are the Leaders in Global Peripheral Stent Implants Space?
- Abbott Laboratories
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cook Medical, Inc.
- Cardinal Health, Inc.
- iVascular SLU
- Medtronic Plc.
- Terumo Corporation
- W. L. Gore & Associates Inc.
Significant Company Developments
December 2023
Abbott Laboratories introduced its latest generation of peripheral drug-eluting stent, the Xience Prime™, featuring an innovative biocompatible polymer coating and a proprietary drug formulation for enhanced drug delivery efficiency. This launch aims to address the unmet clinical needs in peripheral artery disease treatment, offering improved outcomes and durability compared to existing stent options.
March 2024
Boston Scientific Corporation unveiled its next-generation self-expanding nitinol stent, the Eluvia Pro™, designed to optimise vessel conformability and reduce the risk of stent fractures in complex peripheral lesions. The Eluvia Pro™ incorporates advanced engineering features to enhance deliverability and ensure precise placement, providing clinicians with an effective tool for treating challenging peripheral artery diseases.
November 2023
Medtronic plc announced a strategic distribution agreement with a leading healthcare distributor in Asia-Pacific, expanding its market reach for peripheral stent implants in key emerging markets. This partnership aims to leverage the distributor's extensive network and local expertise to enhance product accessibility and support healthcare providers in delivering innovative solutions for peripheral artery revascularisation.
An Expert’s Eye
Continued innovation in stent design, materials, and delivery systems is expected to drive market expansion. Advancements such as bioresorbable stents, drug-eluting stents, and improved coatings contribute to enhanced efficacy and safety, widening the application spectrum of peripheral stent implants.
The increasing incidence of peripheral artery diseases, fuelled by ageing populations and lifestyle factors such as smoking and sedentary behaviour, creates a substantial market opportunity. As the prevalence of conditions such as peripheral artery disease (PAD), and critical limb ischemia (CLI) continues to rise globally, the demand for peripheral stent implants for revascularisation procedures is expected to grow significantly.
The shift towards minimally invasive endovascular interventions, driven by factors such as reduced procedural trauma, shorter recovery times, and lower healthcare costs, is expected to fuel market growth. Peripheral stent implants play a crucial role in these procedures, offering safe and effective solutions for restoring blood flow in diseased peripheral arteries.
Global Peripheral Stent Implants market is Segmented as Below:
By Product:
- Bare Metal Stents (BMS)
- Covered Stents
- Drug Eluting Stents (DES)
By Artery:
- Carotid Artery Stents
- Fem-Pop Artery Stents
- Iliac Artery Stents
- Infrapop Artery Stents
By End User:
- Hospitals
- Ambulatory Surgical Centres/Outpatients
By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Turkey
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Egypt
- Nigeria
- Rest of the Middle East & Africa
1. Executive Summary
1.1. Global Peripheral Stent Implants Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2019 - 2023
3.1. Global Peripheral Stent Implants Market Production Output, by Region, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2019 - 2023
4.1. Global Average Price Analysis, by Product/ Material, US$ Per Unit, 2019 - 2023
4.2. Prominent Factor Affecting Peripheral Stent Implants Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Peripheral Stent Implants Market Outlook, 2019 - 2031
5.1. Global Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Bare Metal Stents (BMS)
5.1.1.2. Covered Stents
5.1.1.3. Drug Eluting Stents (DES)
5.2. Global Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Carotid Artery Stents
5.2.1.2. Fem-Pop Artery Stents
5.2.1.3. Iliac Artery Stents
5.2.1.4. Infrapop Artery Stents
5.3. Global Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Ambulatory Surgical Centers/Outpatients
5.4. Global Peripheral Stent Implants Market Outlook, by Region, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa
6. North America Peripheral Stent Implants Market Outlook, 2019 - 2031
6.1. North America Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Bare Metal Stents (BMS)
6.1.1.2. Covered Stents
6.1.1.3. Drug Eluting Stents (DES)
6.2. North America Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Carotid Artery Stents
6.2.1.2. Fem-Pop Artery Stents
6.2.1.3. Iliac Artery Stents
6.2.1.4. Infrapop Artery Stents
6.3. North America Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Ambulatory Surgical Centers/Outpatients
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. U.S. Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.4.1.2. U.S. Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.4.1.3. U.S. Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.4.1.4. Canada Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.4.1.5. Canada Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.4.1.6. Canada Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Peripheral Stent Implants Market Outlook, 2019 - 2031
7.1. Europe Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Bare Metal Stents (BMS)
7.1.1.2. Covered Stents
7.1.1.3. Drug Eluting Stents (DES)
7.2. Europe Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.2.1. Key Highlights
7.2.1.1. Chemotherapy/ Oncology
7.2.1.2. Paediatrics/Neonatology
7.2.1.3. Analgesia
7.2.1.4. Hematology
7.3. Europe Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Ambulatory Surgical Centers/Outpatients
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Europe Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. Germany Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.2. Germany Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.3. Germany Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.4. U.K. Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.5. U.K. Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.6. U.K. Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.7. France Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.8. France Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.9. France Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.10. Italy Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.11. Italy Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.12. Italy Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.13. Turkey Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.14. Turkey Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.15. Turkey Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.16. Russia Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.17. Russia Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.18. Russia Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.19. Rest of Europe Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.20. Rest of Europe Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.1.21. Rest of Europe Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Peripheral Stent Implants Market Outlook, 2019 - 2031
8.1. Asia Pacific Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Bare Metal Stents (BMS)
8.1.1.2. Covered Stents
8.1.1.3. Drug Eluting Stents (DES)
8.2. Asia Pacific Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Carotid Artery Stents
8.2.1.2. Fem-Pop Artery Stents
8.2.1.3. Iliac Artery Stents
8.2.1.4. Infrapop Artery Stents
8.3. Asia Pacific Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Ambulatory Surgical Centers/Outpatients
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. China Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.2. China Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.3. China Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.4. Japan Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.5. Japan Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.6. Japan Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.7. South Korea Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.8. South Korea Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.9. South Korea Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.10. India Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.11. India Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.12. India Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.13. Southeast Asia Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.14. Southeast Asia Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.15. Southeast Asia Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.16. Rest of Asia Pacific Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.17. Rest of Asia Pacific Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.1.18. Rest of Asia Pacific Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Peripheral Stent Implants Market Outlook, 2019 - 2031
9.1. Latin America Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.1.1. Key Highlights
9.1.1.1. Bare Metal Stents (BMS)
9.1.1.2. Covered Stents
9.1.1.3. Drug Eluting Stents (DES)
9.2. Latin America Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.2.1. Key Highlights
9.2.1.1. Carotid Artery Stents
9.2.1.2. Fem-Pop Artery Stents
9.2.1.3. Iliac Artery Stents
9.2.1.4. Infrapop Artery Stents
9.3. Latin America Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.3.1. Key Highlights
9.3.1.1. Hospitals
9.3.1.2. Ambulatory Surgical Centers/Outpatients
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1. Key Highlights
9.4.1.1. Brazil Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.2. Brazil Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.3. Brazil Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.4. Mexico Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.5. Mexico Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.6. Mexico Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.7. Argentina Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.8. Argentina Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.9. Argentina Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.10. Rest of Latin America Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.11. Rest of Latin America Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.1.12. Rest of Latin America Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Peripheral Stent Implants Market Outlook, 2019 - 2031
10.1. Middle East & Africa Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.1.1. Key Highlights
10.1.1.1. Bare Metal Stents (BMS)
10.1.1.2. Covered Stents
10.1.1.3. Drug Eluting Stents (DES)
10.2. Middle East & Africa Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.2.1. Key Highlights
10.2.1.1. Carotid Artery Stents
10.2.1.2. Fem-Pop Artery Stents
10.2.1.3. Iliac Artery Stents
10.2.1.4. Infrapop Artery Stents
10.3. Middle East & Africa Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.3.1. Key Highlights
10.3.1.1. Hospitals
10.3.1.2. Ambulatory Surgical Centers/Outpatients
10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1. Key Highlights
10.4.1.1. GCC Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.2. GCC Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.3. GCC Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.4. South Africa Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.5. South Africa Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.6. South Africa Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.7. Egypt Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.8. Egypt Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.9. Egypt Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.10. Nigeria Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.11. Nigeria Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.12. Nigeria Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.13. Rest of Middle East & Africa Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.14. Rest of Middle East & Africa Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.1.15. Rest of Middle East & Africa Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2019 - 2031
10.4.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. By End User vs by Artery Heat map
11.2. Manufacturer vs by Artery Heatmap
11.3. Company Market Share Analysis, 2023
11.4. Competitive Dashboard
11.5. Company Profiles
11.5.1. Abbott Laboratories
11.5.1.1. Company Overview
11.5.1.2. Product Portfolio
11.5.1.3. Financial Overview
11.5.1.4. Business Strategies and Development
11.5.2. B. Braun Melsungen AG
11.5.2.1. Company Overview
11.5.2.2. Product Portfolio
11.5.2.3. Financial Overview
11.5.2.4. Business Strategies and Development
11.5.3. Biotronik SE & Co. KG
11.5.3.1. Company Overview
11.5.3.2. Product Portfolio
11.5.3.3. Financial Overview
11.5.3.4. Business Strategies and Development
11.5.4. Boston Scientific Corporation
11.5.4.1. Company Overview
11.5.4.2. Product Portfolio
11.5.4.3. Financial Overview
11.5.4.4. Business Strategies and Development
11.5.5. Cook Medical, Inc.
11.5.5.1. Company Overview
11.5.5.2. Product Portfolio
11.5.5.3. Financial Overview
11.5.5.4. Business Strategies and Development
11.5.6. Cardinal Health, Inc.
11.5.6.1. Company Overview
11.5.6.2. Product Portfolio
11.5.6.3. Financial Overview
11.5.6.4. Business Strategies and Development
11.5.7. iVascular SLU
11.5.7.1. Company Overview
11.5.7.2. Product Portfolio
11.5.7.3. Financial Overview
11.5.7.4. Business Strategies and Development
11.5.8. Medtronic Plc.
11.5.8.1. Company Overview
11.5.8.2. Product Portfolio
11.5.8.3. Financial Overview
11.5.8.4. Business Strategies and Development
11.5.9. Terumo Corporation
11.5.9.1. Company Overview
11.5.9.2. Product Portfolio
11.5.9.3. Financial Overview
11.5.9.4. Business Strategies and Development
11.5.10. W. L. Gore & Associates Inc.
11.5.10.1. Company Overview
11.5.10.2. Product Portfolio
11.5.10.3. Financial Overview
11.5.10.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations
|
BASE YEAR |
HISTORICAL DATA |
FORECAST PERIOD |
UNITS |
|||
 |
2023 |
 |
2019 - 2023 |
 |
2024 - 2031 |
Value: US$ Billion |
|
REPORT FEATURES |
DETAILS |
|
Product Coverage |
|
|
Artery Coverage |
|
|
End Use Coverage |
|
|
Geographical Coverage |
|
|
Leading Companies |
|
|
Report Highlights |
Key Market Indicators, Macro-micro economic impact analysis, Technological Roadmap, Key Trends, Driver, Restraints, and Future Opportunities & Revenue Pockets, Porter’s 5 Forces Analysis, Historical Trend (2019-2021), Market Estimates and Forecast, Market Dynamics, Industry Trends, Competition Landscape, Category, Region, Country-wise Trends & Analysis, COVID-19 Impact Analysis (Demand and Supply Chain) |
Quality assured
